why choose us

First received: January 24, 2023

Clinical Trial: Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hodgkin Lymphoma

Study Type: INTERVENTIONAL


Official Title: A Proof-of-Concept Multicenter Trial Evaluating Response Adapted Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

Brief Summary: The goal of this clinical trial is to study the combination of nivolumab and axatilimab in patients with relapsed/refractory classical Hodgkin Lymphoma.This study will mainly look at if the combination works as expected.

Read more